Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v7-EN Version v2-EN
Language English English
Date Updated 2022-09-29 2022-09-28
Drug Identification Number 01908448 01908448
Brand name BETOPTIC S BETOPTIC S
Common or Proper name BETOPTIC S 0.25% SUSP. BETOPTIC S 0.25% SUSP.
Company Name NOVARTIS PHARMACEUTICALS CANADA INC NOVARTIS PHARMACEUTICALS CANADA INC
Ingredients BETAXOLOL BETAXOLOL
Strength(s) 0.25% 0.25%
Dosage form(s) SUSPENSION SUSPENSION
Route of administration OPHTHALMIC OPHTHALMIC OPHTHALMIC OPHTHALMIC
Packaging size 10ML 10ML
ATC code S01ED S01ED
ATC description ANTIGLAUCOMA PREPARATIONS AND MIOTICS ANTIGLAUCOMA PREPARATIONS AND MIOTICS
Reason for discontinuation Business reasons Business reasons
Anticipated discontinuation date 2022-11-30 2022-09-26
Actual discontinuation date
Remaining supply date 2023-07-31 2023-07-31
Discontinuation status To be discontinued To be discontinued
Discontinuation decision reversal no no
Tier 3 Status No No
Information on remaining supply
Company comments Betoptic S 0.25% Susp. 5mL will continue to be available. Betoptic S 0.25% Susp. 5mL will continue to be available.
Health Canada comments